Martin Bosch

ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany.

ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011.

OncoBeta GmbH is a privately held medical device company based in Garching near Munich, Germany. The German company specializes in the development and commercialization of innovative therapies, particularly the epidermal radioisotope therapy Rhenium-SCT® for non-melanoma skin cancers and keloid scars. OncoBeta was founded in 2010 by Oliver Buck and Doris Zur Muehlen, and the CEO is Shannon D. Brown.

Part of Theilen Holding GmbH, HSM GmbH & Co. KG is a German company that develops, produces, and sells products and systems for pressing recyclable materials, shredding paper, and electronic data carriers. The company is based in Frickingen, Germany. The company was founded in 1971 by Hermann Schwelling, who has been the CEO since 1971. HSM was acquired by Hsm Praezisionsteile & Sicherheitssysteme GmbH I Gr from Ringmetall SE on June 30, 2023.

FVW Beteiligungs- und Verwaltungs GmbH focuses on the management and administration of FVW Beteiligungs GmbH & Co.KG as a general partner. The company was founded on December 4, 2008 and is headquartered in Essen, Germany.

Vetter Injekt-System GmbH & Co. KG is a German company that manufactures data processing equipment.

For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world.

Oncobeta International GmbH operates as a German investment company.

RV Invest GmbH provides business and economic services. The private company is based in Ravensburg, Germany. The CEOs are Udo Johannes Vetter, Gunther Strothe, Wolfgang Kerkhoff. The German company was founded in 2016.

UV-Cap GmbH & Co. KG is private equity fund investing in middle sized companies with a strong growth potential. It requires a control by taking a board seat.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Part of PASCHAL-Werk G. Maier GmbH, PASCHAL Form Work (India) Pvt Ltd. offers comprehensive solutions for formwork design and technology. Founded in 2008, the company is based in Hyderabad, India. The LOGO.pro formwork solution can be anchored from just one side or in the conventional manner. The Indian company's system devices for receiving and deflecting loads from concrete pressure, and lift from single-sided formworks are innovative solutions for the construction of walls, slabs, and columns. For more information, visit their website.

Part of Arme Dienstmägde Jesu Christi eV, Otto-Fricke-Krankenhaus Paulinenberg GmbH is a hospital that is based in Bad Schwalbach, Germany. The hospital is part of the Joho-Verbund network, which includes three hospitals in three locations. The hospital offers specialized treatment for older patients, including geriatrics and orthopedics. The German company also provides social services and advice on care, illness, and disability. The CEO of the company is Thomas Reckmeyer. In 2012, Otto-Fricke-Krankenhaus Paulinenberg was acquired by St. Josefs-Hospital Wiesbaden GmbH.

St. Josefs-Hospital Rheingau GmbH owns and operates hospital. The company is headquartered in Rudesheim am Rhein, Germany.

Repligen GmbH manufactures chromatography columns. The columns are used in process development and clinical manufacturing of biological drugs. Its products include MaxiChrom, MiniChrom, MiniColumn and ValiChrom. The company is headquartered in Ravensberg, Germany.

UV-Cap Verwaltungs GmbH (UV-Cap) invests is a private equity firm, founded in 2004. The firm is headquartered in Ravensburg, Germany.

PASCHAL-Werk G. Maier GmbH is a German company that manufactures metal structures. The private company is based in Steinach, Germany. and has subsidiaries in India. The CEOs are Michael Stoevelbaek, Barbara R. Vetter. The company was founded in 1964 by Josef Maier, Gertrud Maier.

National Commercial Bank Jamaica Ltd. engages in the provision of commercial banking and financial services. It operates its business through following segments: Retail and Small and Medium-Sized Enterprises (SMEs); Payment Services; Corporate Banking; Treasury and Correspondent Banking; Wealth, Asset Management, and Investment Banking; Life Insurance and Pension Fund Management; General Insurance; and Other. The Retail and SMEs segment incorporates the provision of banking services to individual and small and medium business clients, and money remittance services. The Payment Services segment focuses on the provision of card related services. The Corporate Banking segment deals with the provision of banking services to large corporate clients. The Treasury and Correspondent Banking segment includes the company's liquidity and investment management function, management of correspondent bank relationships, and relationships with other financial institutions as well as foreign currency dealing activities. The Wealth, Asset Management, and Investment Banking segment engages in the provision of stock brokerage, securities trading, investment management, and other financial services. The Life Insurance and Pension Fund Management segment incorporates life insurance, pension, and investment management services. The General Insurance segment focuses on the provision of property and casualty insurance services. The Other segment deals with the brokerage services, trustee services, and registrar and transfer agent services. The company was founded in 1837 and is headquartered in Kingston, Jamaica.

Portland Investment Counsel, Inc. is an SEC-registered investment advisor located in Mississauga, Ontario with an additional office in Burlington, Ontario. The firm manages the AIC Advantage Fund, the AIC Diversified Canada Fund, the AIC Canadian Focused Fund, the AIC Diversified Canada Corporate Class, the AIC Canadian Focused Corporate Class, the AIC Global Financial Split Corp., the AIC Preferred Income Fund, the AIC Advantage Fund II, the AIC Advantage II Corporate Class, the AIC Global Advantage Corporate Class, the AIC American Advantage Fund, the AIC Global Advantage Fund and the AIC Global Wealth Management Fund.

Portland Holdings, Inc. is a Canadian company that provides investment services. The private company is based in Burlington, CA. and has subsidiaries in Canada, Trinidad and Tobago and United States.

I. G. Investment Management Ltd. (IGIM) is a Canadian mutual fund manager headquartered in Winnipeg, Manitoba. In 2017, IGM Financial Inc. (TSE: IGM) combined the investment management functions of Investors Group, Inc. and Mackenzie Investments to form a single global investment management organization. The firm is a subsidiary of Investors Group, Inc., ultimately held by Power Corp. of Canada (TSE: POW). IGIM offers a diverse group of mutual funds covering different industry sectors for individual and institutional investors.

Part of The Bank of Nova Scotia, Regal Capital Planners Ltd is a Canadian company that provides financial advisory services. The company is based in Waterloo, Canada. Regal Capital Planners was acquired by Cartier Partners Financial Group, Inc. on April 20, 2000 for $29.95 million.

Mandeville Holdings, Inc. provides investment advisory services. The firm serves individuals, institutions, foundations and not-for-profit organizations. The company was founded by Michael Anthony Lee-Chin and is headquartered in Burlington, Canada.

Royal Ontario Museum operates museums. The company is headquartered in Toronto, Canada.

RadioMedix, Inc. is a clinical stage biotechnology company based in Houston, TX, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The private company commercializes radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy. The company covers the entire value chain from drug discovery to sponsoring and conducting clinical trials. The company has established contract service facilities for academic and industrial partners, including a drug discovery center, pre-clinical core facility, and a CGMP manufacturing and analytical suite for human clinical trials and commercial phase manufacturing of the radiopharmaceuticals. The company has also established a large-scale post-approval commercial manufacturing facility known as the Spica Center. The company's pipeline includes Detectnet™, a diagnostic agent for management of somatostatin expressing neuroendocrine cancers using PET/CT technology. The company was founded by Ebrahim S. Delpassand and he has been the CEO since incorporation.

Portland Private Equity LP (Portland Private Equity) is a private equity firm founded in 2007. The firm is headquartered in Saint Michael, Barbados.

The Trinidad & Tobago Manufacturers' Association functions as a trade association. The private company is based in Trinidad and Tobago.